Causes and interventions for malnutrition in patients undergoing maintenance dialysis

Blood Purification

Volumn 15, Issue 2, 1997, Pages 112-120

  Fouque, Denis ^a  

^a Edouard Hcrriot Hospital   (France)

Author keywords

Amino acid; Erythropoietin; Growth hormone; Hemodialysis; Insulin like growth factor 1; Intradialytic parenteral nutrition; Malnutrition; Peritoneal dialysis

Indexed keywords

AMINO ACID; GLUCOSE; GROWTH HORMONE; INSULIN; LIPID; NITROGEN; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN C; VITAMIN;

ACIDOSIS; ANOREXIA; BIOSYNTHESIS; CATABOLISM; CONFERENCE PAPER; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DIALYSIS; FOOD INTAKE; HEMODIALYSIS; HUMAN; MALNUTRITION; NITROGEN BALANCE; NUTRITIONAL STATUS; PARENTERAL NUTRITION; PRIORITY JOURNAL;

HUMANS; NUTRITION PHYSIOLOGY; RENAL DIALYSIS;

EID: 8044230699     PISSN: 02535068     EISSN: 14219735     Source Type: Journal    
DOI: 10.1159/000170322     Document Type: Article

References (61)

1. Kluthc R. Luttgrcn FM, Capctinau T, Heinzc V. Katz N, Sudhof TA: Protein requirements in maintenance hemodialysis. AmJ Clin Nutr 1978:31:1818-1820.
2. Kopple JD: Abnormal amino acid and protein metabolism in uremia. Kidney lnt 1978:14:340-348.
3. Saluskv IB., Fine RN., Nelson P., Blu-menkrantz MJ, Kopple JD: Nutritional status of children undergoing continuous ambulatory peritoneal dialysis. Am J Clin Nutr 1983:38: 599-611.
4. Wolfson M. Strong CJ. Mintum D. Gray DK. Kopple JD: Nutritional status and lymphocyte function in maintenance hemodialysis patients. Am J Clin Nutr 1984:39:547-555.
5. Carlson DM., Duncan DA, Naessens JM., Johnson WJ: Hospitalization in dialysis patients. Mayo Clin Proc 1984;59:769-775.
6. Evans RW, Mannine DL. Garrison LP. Ilart LG. Blagg CR, Gutman RA, IIull AR, Lowrie EG: The quality of life of patients with end-stage renal disease. N Engl J Med 1985: 312:553-559.
7. Bergstrom J: Nutrition and adequacy of dialysis in hemodialysis patients. Kidney Int 1993:43(suppl 4l):26l-267.
8. Fouque D, Joly MO, Laville M. Beaufrère B. Goudable J. Pozet N. Labceuw M, Châtelain P, Zech P: Increase of serum insulin-like growth factor I (IFG 1) during chronic renal failure is reduced by low-protein diet. Miner Electrolyte Metab 1992;18:276-279.
9. Ciancaruso B., Capuano A, D’Ama-ro E, Ferrera N., Nastasi A., Conte G., Bellizi V., Andreucci VE: Dietary compliance to a low protein and phosphate diet in patients with chronic renal failure. Kidney Int 1989;36(suppl 27): 173—176.
10. Allman MA. Stewart PM. Tiller DJ. Horvath JS. Duggin GG. Truswell AS: Energy supplementation and the nutritional status of hemodialysis patients. Am J Clin Nutr 1990: 51:558-562.
11. Eknoyan G., Beck GJ, Breycr JA., Kopple JD., Kusek JW., Levey AS., Striker GE: Design and preliminary results of the mortality and morbidity of hemodialysis (MMFID) pilot study (abstract). J Am Soc Nephrol 1994:5:513.
12. Jacob V., Le Carpentier JE., Salzano S., Naylor V, Wild G., Brown CB., El Nahas AM: IGF-1, a marker of un-demutrition in hemodialysis patients. Am J Clin Nutr 1990;52:39-44.
13. Bergstrom J, Mamoun H, Ander-stam B. Soderstcn P: Middle molecules isolated from uremic ultrafiltrate and normal urine induce dose-dependem inhibition of appetite in rat (abstract). J Am Soc Nephrol 1994:5:488.
14. Lindsay RM. Spanner E: A hypothesis: The protein catabolic rate is dependent upon the type and amount of treatment in dialyzed uremic patients. Am.1 Kidney Dis 1989; 13: 382-389.
15. Borah M., Schoenfeld PY., Gotch FA., Sargent JA., Wolfson M, Humphreys MH: Nitrogen balance in intermittent hemodialysis therapy. Kidney lnt 1978;14:497-500.
16. Guttierez A., Alvestrand A, Wahren J., Bergstrom J: Effect of in vivo contact between blood and dialysis membranes on protein catabolism in humans. Kidney lnt 1990:38: 487-494.
17. Giordano C., De Pascale C., De Cris-lofaro D, Capodicasa G., Balcstrieri C., Baczyck K: Protein malnutrition in the treatment of chronic uremia; in Berlyne G (ed): Nutrition in Renal Disease. Baltimore, Williams & Wilkins, 1968. pp 23-24.
18. Kopple JD., Swendseid ME, Shina-berger JII., Umezawa CY: The free and bound amino acids removed by hemodialysis. Trans Am Soc Artif Intern Organs 1973;19:309-313.
19. Ikizler TA., Flakoll PJ., Parker RA, Hakim RM: Amino acid and albumin losses during hemodialysis. Kidney lnt 1994:46:830-837.
20. Levin NW: Dialyzer reuse: A currently acceptable practice. Semin Dial1993:6:89-90.
21. Kaplan AA. Hallcv SE. Lapkin RA. Graeber CW: Dialysate protein losses with bleach processed polysul-phone dialyzers. Kidney lnt 1995; 47:573-578.
22. Giordano C. DeSanto NG. Capodicasa G. DiLeo VA. DiScrafino A. Cirillo D. Esposito R. Fiore R. Damiano L, Buonadonna L, Cocco F, DiLorio B: Amino acid losses during CAPD. Clin Nephrol 1980: 14:230-232.
23. Kopple JD. Blummenkranlz MJ, Jones MR. Moran JK, Coburn JW: Plasma amino acid levels and amino acid losses during continuous ambulatory peritoneal dialysis. An: J Clin Nutr 1982:36:395-402.
24. Blummcnkrantz MJ., Gahl GM, Kopple JD., Kamdar AV., Jones MR., Kessel M., Cobum JW: Protein losses during peritoneal dialysis. Kidney Int 1981;19:539-602.
25. De Fronzo RA. Tobin JD. Rowe JW. Andres R: Glucose intolerance in uremia: Quantification of pancreatic beta cell sensitivity to glucose and tissue sensitivity to insulin. J Clin Invest 1978:62:425-435.
26. Fouque D: Insulin-like growth factor (IGF)-1 resistance in chronic renal failure. Miner Electrolvte Metab 1996;22:133-137.
27. Birge SJ. Hadded JG: 25-Hydroxy-cholecalciferol stimulation of muscle metabolism. J Clin Invest 1974; 56:1100-1107.
28. May RC, Kelly RA., Mitch WE: Mechanisms for defects in muscle protein metabolism in rats with chronic uremia. J Clin Invest 1987: 79:1099-1103.
29. Mitch WE, May RC. Maroni BJ, Druml W: Protein and amino acid metabolism in uremia: Influence of metabolic acidosis. Kidney Int 1989:36(suppl 27):205-207.
30. Rcaich D, Channon SM, Scrim-geour CM. Daley SE. Wilkinson R. Goodship THJ: Correction of acidosis in humans with CRF decreases protein degradation and amino acid degeneration. Am J Physiol 1993: 265:E230-E235.
31. Simenhoff ML, Dunn SR. Fitzpatrick ME. Emery S. Sandine W, Ayres J: Metabolic and nutritional consequences of contaminated small bowel syndrome (CSBS) in chronic renal failure (CRF) using freeze-dried L. acidophilus (LBA) (abstract). J Am Soc Nephrol 1994: 5:954.
32. Barany P, Freyschuss U, Pcttcrsson E, Bergstrom J: Treatment of anemia in hemodialysis patients with erythropoietin: Long-term effects on exercise capacity. Clin Sci 1993:84: 441-447.
33. Mayer G, Thurn J, Cada EM, Stummvoll HK, Graf H: Working capacity is increased following recombinant human erythropoietin treatment. Kidnev lnt 1988:34:525-528.
34. Canaud B., Bouloux C., Rivory JP., Taib J., Garred U., Florence P., Mion C: Ervthropoietin-induced changes in protein nutrition: Quantitative assessment by urea kinetic modeling analysis. Blood Purif 1990:8:301 -308.
35. Van Geelen JA, Nube MJ, Zuur-bricr PA: Influence of erythropoietin treatment on urea kinetic parameters in hemodialysis patients. Clin Nephrol 1991:35:165-170.
36. Garibotto G, Gurrcri G, Robaudo C. Saffioti S. Magnasco A. Sofia A, Marchclli M. Sala MR: Erythropoietin treatment and amino acid metabolism in hemodialysis patients. Nephron 1993:65:533-536.
37. Raybould HE. Plourdc V. Zittcl T. Bovcr J. Quintero E: Gastric emptying of solids but not liquids is decreased in rats with chronic renal failure. Dig Dis Sci 1994:39:2301-2305.
38. Bird NJ. Streather CP. O’Doherty MJ. Barton IK. Gaunt JI., Nunan TO: Gastric emptying in patients with chronic renal failure on continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1993:9: 287-290.
39. Hccking E, Kohler H., Zobel R., Lcmmcl EM., Madcr H., Opfcrkuch W., Prellwitz W., Keint HJ., Muller D: Treatment with essential amino acids in patients on chronic hemodialysis: A double blind cross-over study. Am J Clin Nutr 1978:31: 1821-1826.
40. Golpcr TA: Severe malnutrition II. Semin Dial 1993:6:362-364.
41. Wolfson M: The cost and bother of intradialytic parenteral nutrition arc not justified by scientific studies. ASAIO.I 1993:39:864-867.
42. Wolfson M: Use of intradialytic parenteral nutrition in hemodialysis. Am J Kidney Dis 1994:23:856-858.
43. Capclli JP. Kushncr H. Camiscioli TC. Chen SM. Torres MA: Effect of intradialytic parenteral nutrition on mortality rates in end-stage renal disease care. Am J Kidney Dis 1994; 23:808-816.
44. Cano N., Labastie-Cocyrehourcq J., Lacombe P, Slroumza P., Dicostanzo-Dufclel J., Durbec JP., Coudray-Lucas C., Cynober L: Perd ialyt ic parenteral nutrition with lipids and amino acids in malnourished hemodialysis patients. Am J Clin Nutr 1990:52:726-730.
45. Wolfson M. Jones MR. Kopple JD: Amino acid losses during hemodialysis with infusion of amino acids and glucose. Kidney Int 1982:21: 500-506.
46. Smollc KH. Kaufmann P. I lozer H. Druml W: Intradialytic parenteral nutrition in malnourished patients on chronic haemodialysis therapy. Nephrol Dial Transplant 1995; 10: 1411-1416.
47. Chazot C. Shamir E. Matias B, Kopple JD: Provision of amino acids by dialysis during maintenance hemodialysis (abstract). J Am Soc Nephrol 1995;6:574.
48. Kopple JD., Bernard D., Mcssana J., Swartz, R., Bergström J., Lindholm B., Lim V, Brunori G., Lciscrowitz M., Bier DM., Stegink LD., Marlis L., Al-grim Boyle C., Serkes KD, Vonesh E., Jones MR: Treatment of malnourished CAPD patients with an amino acid based dialysate. Kidney int 1995:47:1148-1157.
49. Faller B. Aparieio M. Faict D. Dc Vos C. De Precigout V. Larroumet N. Guibcrcau R. Joncs M. Peluso F: Clinical evaluation of an optimized 1.1% amino acid solution for peritoneal dialysis. Nephrol Dial Transplant 1995; 10:1432-1437.
50. Cano N. Luc G. Stroumza P. Lacombe P. Durbec JP: Serum lipoprotein changes after prolonged intralipid infusion in malnourished haemodialysis patients. Am.J Clin Nutr 1994:13:111-115.
51. Chertow GM., Ling, I., Lew NL., Lazarus JM, Lowrie EG: The association of intradialytic parenteral nutrition administration with survival in hemodialysis patients. Am J Kidney Dis 1994;24:912-920.
52. Snyder S., Bergen C., Sigler MH., Tcchan BP: Intradialytic parenteral nutrition in chronic hemodialysis patients. ASAIO Trans 1991:37: M373-M375.
53. Gupta BK. Plotner E. Spinowitz BS. Charytan C: Severe malnutrition IV. Semin Dial 1993:6:366-369.
54. Tonshoff B. Schaeffer F. Mehls O: Disturbance of growth hormone-in-sulin-like growth factor axis in uremia. Pediatr Nephrol 1990:4:654-662.
55. Kopple JD: The rationale for the use of growth hormone or insulin-like growth factor 1 in adult patients with renal failure. Miner Electrolyte Mctab 1992:18:269-275.
56. Ziegler TR, Lazarus JM., Young LS., Hakim R., Wilmore DW: Effects of recombinant human growth hormone in adults receiving maintenance hemodialysis. J Am Soc Nephrol 1991:2:1 130-1135.
57. Schulman G., Wingard RL., Hutchison RL., Lawrence P, Hakim RM: The effects of recombinant human growth hormone and intradialytic parenteral nutrition in malnourished hemodialysis patients. Am J Kidney Dis 1993;21:527-534.
58. Ikizler TA. Wingard RL Breyer JA. Schulman G. Parker RA. Hakim RM: Short-term effects of recombinant human growth hormone in CAPD patients. Kidney Int 1994: 46:1178-1183.
59. Kang DH. Lee SW. Kang SW. Kim HS. Choi KH. Lee HY. Han DS: Recombinant human growth hormone (rhGH) improves nutritional status of undernourished adult CAPD patients (abstract). J Am Soc Nephrol 1994:5:494.
60. Iglesias P. Fcrnandes-Rcyes MJ. Diez JJ. Palacios C. Miguel JL. Martinez-Ara J. Gomez-Pan A. Selgas R: Nutritional effects of recombinant human growth hormone in malnourished dialysis patients. Preliminary report of a controlled randomized study (abstract). Proc 13th Int Congr Nephrol. Madrid. July 2-6. 1995, p423.
61. Peng S. Fouque D. Kopple J D: Insu-lin-like growth factor-I (IGF-I) causes anabolism in malnourished CAPD patients (abstract). J Am Soc Nephrol 1993:3:414.